The treatment of the hemolytic-uremic syndrome with inhibitors of platelet function

Charles A. Thorsen, Ennio C. Rossi*, David Green, Frank A. Carone

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

In four patients with clinical and laboratory manifestations of the hemolytic-uremic syndrome, the administration of aspirin and dipyridamole was associated with a dramatic and rapid increase in the platelet count. In three of the four patients there was also improvement in neurologic or renal function. No subject experienced bleeding or other untoward effects. We conclude that a trial of aspirin and dipyridamole therapy is warranted early in the course of the hemolytic-uremic syndrome.

Original languageEnglish (US)
Pages (from-to)711-716
Number of pages6
JournalThe American journal of medicine
Volume66
Issue number4
DOIs
StatePublished - Jan 1 1979

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'The treatment of the hemolytic-uremic syndrome with inhibitors of platelet function'. Together they form a unique fingerprint.

Cite this